Multi-agent therapy with pomalidomide, bortezomib,...

Clinical Lymphoma Myeloma and Leukemia 2019 / 10 Vol. 19; Iss. 10

Multi-agent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone and daratumumab (Pom-PAD-Dara) in relapsed/ refractory multiple myeloma

Zhou, Xiang, Steinhardt, Max, Grathwohl, Denise, Meckel, K., Nickel, K., Leicht, Hans-Benno, Krummenast, Franziska, Einsele, Hermann, Kortüm, K.M., Rasche, Leo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.09.469
Date:
October, 2019
File:
PDF, 66 KB
2019
Conversion to is in progress
Conversion to is failed